{"organizations": ["Real-World & Late Phase Research", "Industry Standard Research", "Research Triangle Park", "United States Quintiles", "Quintiles"], "uuid": "73661dbf2f2b9db81c4077f584bfb6601e9b49e0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "businesswireindia.com", "main_image": "", "site_section": "http://businesswireindia.com/RSSFeeds/cat-business-finance.xml", "section_title": "BusinessWire India.com - Business/ Finance", "url": "http://businesswireindia.com/news/news-details/quintiles-recognized-as-phase-iv-services-leader-third-consecutive-yea/45445", "country": "US", "title": "Quintiles Recognized as Phase IV Services Leader for Third Consecutive Year", "performance_score": 0, "site": "businesswireindia.com", "participants_count": 0, "title_full": "Quintiles Recognized as Phase IV Services Leader for Third Consecutive Year", "spam_score": 0.0, "site_type": "news", "published": "2015-09-29T08:23:00.000+03:00", "replies_count": 0, "uuid": "73661dbf2f2b9db81c4077f584bfb6601e9b49e0"}, "author": "", "url": "http://businesswireindia.com/news/news-details/quintiles-recognized-as-phase-iv-services-leader-third-consecutive-yea/45445", "ord_in_thread": 0, "title": "Quintiles Recognized as Phase IV Services Leader for Third Consecutive Year", "locations": ["N.C."], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Andrea Spannheimer"], "text": "Tuesday, September 29, 2015 10:53AM IST (5:23AM GMT) Quintiles Recognized as Phase IV Services Leader for Third Consecutive Year Remains preferred provider among biopharmaceutical companies N.C., Research Triangle Park, United States Quintiles has been named the market leader in Phase IV services for the third year in a row, according to the 2015 CRO Quality Benchmarking – Phase IV Service Providers Report from Industry Standard Research (ISR). Quintiles was selected as the preferred provider among biopharmaceutical companies for Phase IV services based on a survey of 110 global biopharmaceutical representatives. In the report, Quintiles was highlighted as a leader across a number of key service quality metrics, including its service breadth, global footprint and technology that enables real-time data access delivered by its award-winning Quintiles Infosario® platform. “We are proud to be honored once again for our leadership in Phase IV services across all of our customer segments,” said Andrea Spannheimer, senior vice president, Real-World & Late Phase Research at Quintiles. “This acknowledgement reflects our unmatched depth and breadth of expertise, as well as scientific affairs thought leadership and services, which are required to provide the right approach to the right question for our customers worldwide. We especially want to thank our talented employees – this recognition is a testament to their tireless dedication.” Compared to the other 33 Phase IV Contract Research Organizations noted in the report, Quintiles was a top performer in a number of selection criteria including:", "external_links": [], "published": "2015-09-29T08:23:00.000+03:00", "crawled": "2015-09-29T08:50:39.687+03:00", "highlightTitle": ""}